Adrian Gadano Selected Research

Simeprevir

2/2016

Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adrian Gadano Research Topics

Disease

8	Infections 01/2021 - 09/2005
7	Fibrosis (Cirrhosis) 08/2022 - 01/2011
6	Chronic Hepatitis B 08/2013 - 03/2006
5	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 03/2014
4	Chronic Hepatitis C 11/2016 - 12/2014
3	Peritonitis 01/2021 - 03/2009
2	Hepatitis C 01/2017 - 01/2017
2	Persistent Infection 01/2015 - 01/2011
2	Wounds and Injuries (Trauma) 03/2010 - 08/2008
1	Pneumonia (Pneumonitis) 01/2021
1	Bacterial Infections (Bacterial Infection) 04/2019
1	Hypoxia (Hypoxemia) 12/2018
1	Non-alcoholic Fatty Liver Disease 10/2018
1	Chronic Renal Insufficiency 09/2016
1	Exanthema (Rash) 03/2016
1	Anemia 03/2016
1	Gastrointestinal Hemorrhage (Hematochezia) 05/2015
1	Autoimmune Hepatitis 03/2015
1	Multiple Sclerosis 03/2015
1	Disease Progression 01/2015
1	Liver Diseases (Liver Disease) 08/2013
1	Reinfection 08/2013
1	Hepatitis B 08/2013
1	Kidney Diseases (Kidney Disease) 01/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2011
1	Communicable Diseases (Infectious Diseases) 01/2011
1	HIV Infections (HIV Infection) 01/2011
1	Renal Insufficiency (Renal Failure) 03/2009
1	End Stage Liver Disease 08/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2005
1	Parasitemia 09/2005
1	Leukemia 09/2005
1	Chagas Disease (American Trypanosomiasis) 09/2005

Drug/Important Bio-Agent (IBA)

6	entecavir FDA Link 08/2013 - 03/2006
5	daclatasvirIBA 01/2018 - 01/2016
5	NucleosidesIBA 08/2013 - 03/2006
4	Ribavirin (Virazole)FDA LinkGeneric 11/2016 - 12/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 05/2015
3	Hepatitis B e AntigensIBA 01/2015 - 03/2006
2	CreatinineIBA 08/2022 - 03/2009
2	telaprevirIBA 11/2016 - 03/2016
2	Lamivudine (Epivir)FDA Link 11/2007 - 03/2006
1	CystatinsIBA 08/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	CytokinesIBA 12/2018
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2016
1	Urea (Carbamide)FDA LinkGeneric 09/2016
1	Hemoglobins (Hemoglobin)IBA 03/2016
1	SimeprevirIBA 02/2016
1	peginterferon lambda-1aIBA 01/2016
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2016
1	InterferonsIBA 01/2016
1	Proton Pump InhibitorsIBA 05/2015
1	Interferon-betaIBA 03/2015
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2015
1	asunaprevirIBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2013
1	hepatitis B hyperimmune globulinIBA 08/2013
1	Immunoglobulins (Immunoglobulin)IBA 08/2013
1	Tenofovir (Viread)FDA Link 09/2012
1	Antiviral Agents (Antivirals)IBA 09/2012
1	Hyaluronic Acid (Hyaluronan)IBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2011
1	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2011
1	BilirubinIBA 03/2009
1	benzonidazole (benznidazole)IBA 09/2005

Therapy/Procedure

11	Liver Transplantation 02/2022 - 09/2005
6	Therapeutics 05/2015 - 11/2007
1	Contraindications 01/2011
1	Highly Active Antiretroviral Therapy (HAART) 01/2011
1	Dental Care 03/2010
1	Transplantation 09/2005